Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,721 to 1,740 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility. | Gut Liver | 2020 | 31533396 | PubTator, text mining | PubMed |
| Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML). | Leukemia | 2020 | 31462736 | PubTator, text mining | PubMed |
| Evaluation of ERK as a therapeutic target in acute myelogenous leukemia. | Leukemia | 2020 | 31455850 | PubTator, text mining | PubMed |
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. | Haematologica | 2020 | 31439677 | PubTator, text mining | PubMed |
| Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing. | Leukemia | 2020 | 31435024 | PubTator, text mining | PubMed |
| Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms. | Semin Cancer Biol | 2020 | 31408723 | PubTator, text mining | PubMed |
| Fusion transcripts: Unexploited vulnerabilities in cancer? | Wiley Interdiscip Rev RNA | 2020 | 31407506 | PubTator, text mining | PubMed |
| Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia. | Haematologica | 2020 | 31296572 | PubTator, text mining | PubMed |
| Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity. | Gut | 2020 | 31076402 | PubTator, text mining | PubMed |
| Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC. | Haematologica | 2020 | 30975912 | PubTator, text mining | PubMed |
| Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. | Mol Psychiatry | 2020 | 30610198 | PubTator, text mining | PubMed |
| Genome-wide characterization of copy number variations in diffuse large B-cell lymphoma with implications in targeted therapy. | Precis Clin Med | 2019 | 35693879 | PubTator, text mining | PubMed |
| Mechanisms of resistance to PARP inhibitors - an evolving challenge in oncology. | Cancer Drug Resist | 2019 | 35582591 | PubTator, text mining | PubMed |
| Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells. | Blood Sci | 2019 | 35402786 | PubTator, text mining | PubMed |
| Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy. | Natl Sci Rev | 2019 | 34691895 | PubTator, text mining | PubMed |
| [Genetic characteristics and prognosis of mixed phenotype acute leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2019 | 32397026 | PubTator, text mining | PubMed |
| The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis. | FASEB Bioadv | 2019 | 32095781 | PubTator, text mining | PubMed |
| Identification of the Key Factors Related to Bladder Cancer by lncRNA-miRNA-mRNA Three-Layer Network. | Front Genet | 2019 | 32047516 | PubTator, text mining | PubMed |
| UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer. | Front Oncol | 2019 | 32010618 | PubTator, text mining | PubMed |
| Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group. | Hemasphere | 2019 | 31976488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=87